Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Class A Units [Member]
Class B Units [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 2,000 $ 68,028,000 $ (56,585,000) $ 11,445,000
Beginning balance, shares at Dec. 31, 2019 4,396     24,496,197      
Sale of common stock from private placement $ 1,000 4,443,000 4,444,000
Sale of common stock from private placement, shares       4,237,833      
Fair value of warrants issued to Series A Preferred stockholders (3,951,000) (3,951,000)
Conversion of Series A Preferred to common stock
Conversion of Series A Preferred to common stock, shares (1,150)     741,933      
Fair value of common shares issued for services 896,000 896,000
Fair value of common shares issued for services, shares       769,050      
Fair value of vested restricted stock awards 1,209,000 1,209,000
Fair value of vested restricted stock awards, shares       22,050      
Fair value of vested stock options and warrants 774,000 774,000
Net loss (5,370,000) (5,370,000)
Ending balance, value at Jun. 30, 2020 $ 3,000 71,399,000 (61,955,000) 9,447,000
Ending balance, shares at Jun. 30, 2020 3,246     30,267,063      
Beginning balance, value at Mar. 31, 2020 $ 3,000 68,449,000 (58,531,000) 9,921,000
Beginning balance, shares at Mar. 31, 2020 3,246     28,962,589      
Sale of common stock from private placement 1,014,000 1,014,000
Sale of common stock from private placement, shares       845,000      
Fair value of common shares issued for services 575,000 575,000
Fair value of common shares issued for services, shares       448,449      
Fair value of vested restricted stock awards 968,000 968,000
Fair value of vested restricted stock awards, shares       11,025      
Fair value of vested stock options and warrants 393,000 393,000
Net loss (3,424,000) (3,424,000)
Ending balance, value at Jun. 30, 2020 $ 3,000 71,399,000 (61,955,000) 9,447,000
Ending balance, shares at Jun. 30, 2020 3,246     30,267,063      
Beginning balance, value at Dec. 31, 2020 $ 3,065,000 $ 5,000 89,216,000 (81,541,000) 10,745,000
Beginning balance, shares at Dec. 31, 2020 2,006   2,642,159 47,795,009      
Ending balance, value at Mar. 31, 2021 $ 6,000 112,978,000 (89,886,000) 23,098,000
Ending balance, shares at Mar. 31, 2021 1,706     62,633,282      
Beginning balance, value at Dec. 31, 2020 $ 3,065,000 $ 5,000 89,216,000 (81,541,000) 10,745,000
Beginning balance, shares at Dec. 31, 2020 2,006   2,642,159 47,795,009      
Sale of common stock from public offering $ 1,000 14,128,000 14,129,000
Sale of common stock from public offering, shares       9,375,000      
Issuance of common stock from warrant exercise 1,103,000 1,103,000
Issuance of common stock from warrant exercise, shares       1,036,600      
Issuance of common stock from option exercise 377,000 $ 377,000
Issuance of common stock from option exercise, shares       332,730     332,730
Fair value of common shares issued to settle note payable – related party 200,000 $ 200,000
Fair value of common shares issued to settle note payable - related party, shares       194,175      
Fair value of common shares issued to settle lawsuit 678,000 678,000
Fair value of common shares issued to settle lawsuit, shares       600,000      
Conversion of Series A Preferred to common stock
Conversion of Series A Preferred to common stock, shares (300)     272,728      
Fair value of common shares issued for services 1,769,000 1,769,000
Fair value of common shares issued for services, shares       1,117,467      
Fair value of vested restricted stock awards 905,000 905,000
Fair value of vested restricted stock awards, shares       247,703      
Fair value of vested stock options and warrants 870,000 870,000
Extinguishment of derivative liability upon exercise of warrants 2,300,000 2,300,000
Fair value of common shares issued to settle accrued expenses 281,000 281,000
Fair value of common shares issued to settle accrued expenses, shares       182,397      
Fair value of warrants issued to officer to modify note payable 287,000 287,000
Conversion of Class B Units to common shares $ (3,065,000) 3,065,000
Conversion of Class B Units to common shares, shares     (2,642,159) 2,642,159      
Net loss (20,157,000) (20,157,000)
Ending balance, value at Jun. 30, 2021 $ 6,000 115,179,000 (101,698,000) 13,487,000
Ending balance, shares at Jun. 30, 2021 1,706   63,795,968      
Beginning balance, value at Mar. 31, 2021 $ 6,000 112,978,000 (89,886,000) 23,098,000
Beginning balance, shares at Mar. 31, 2021 1,706     62,633,282      
Fair value of common shares issued to settle note payable – related party 200,000 200,000
Fair value of common shares issued to settle note payable - related party, shares       194,175      
Fair value of common shares issued to settle lawsuit 678,000 678,000
Fair value of common shares issued to settle lawsuit, shares       600,000      
Fair value of common shares issued for services 355,000 355,000
Fair value of common shares issued for services, shares       307,956      
Fair value of vested restricted stock awards 458,000 458,000
Fair value of vested stock options and warrants 422,000 422,000
Extinguishment of derivative liability upon exercise of warrants 14,000 14,000
Fair value of common shares issued to settle accrued expenses 74,000 74,000
Fair value of common shares issued to settle accrued expenses, shares       60,555      
Net loss (11,812,000) (11,812,000)
Ending balance, value at Jun. 30, 2021 $ 6,000 $ 115,179,000 $ (101,698,000) $ 13,487,000
Ending balance, shares at Jun. 30, 2021 1,706   63,795,968